Sodium–glucose cotransporter 2 inhibitors for hypertension in cardiovascular–kidney–metabolic syndrome

Documenti analoghi

• Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia
  di: Yuri Sakai Ishizaki, et al.
  Pubblicazione: (2024)
• Impaired glucose tolerance and insulin resistance in a prenatally‐androgenized rat model of polycystic ovary syndrome in later life
  di: Mahbanoo Farhadi‐Azar, et al.
  Pubblicazione: (2024)
• Acute systemic and energy metabolism responses to velocity‐based resistance training following an oral glucose load in individuals with excess body weight
  di: Hugo Alejandro Carrillo‐Arango, et al.
  Pubblicazione: (2025)
• NPAS2, transcriptionally activated by ARRB1, promotes the malignant behaviours of lung adenocarcinoma cells and regulates the reprogramming of glucose metabolism
  di: Shenglan Wang, et al.
  Pubblicazione: (2024)
• Housing temperature influences exercise‐induced glucose regulation and expression of exerkines in mice
  di: Zhijian Rao, et al.
  Pubblicazione: (2024)